LEXINGTON, Ky. (Oct. 7, 2022) — The University of Kentucky Markey Cancer Center received a grant through the Alliance for Equity in Cancer Care (the Alliance), an initiative funded by the Merck Foundation (the Foundation). The Alliance is designed to make cancer care more equitable in the U.S. by helping patients who live in underserved communities receive timely access to high-quality, culturally responsive care.
Nearly 40% of Americans will be diagnosed with cancer in their lifetime. Members of racial and ethnic minority groups, those living in rural areas, low-income individuals and the uninsured are disproportionately affected by cancer, yet often have limited access to cancer screenings, care and treatment.
Kentucky consistently bears one of the highest cancer burdens in the nation — ranking first overall in new cancer cases and deaths — with more than 30,000 new cases and over 10,100 deaths each year. In addition, the Commonwealth has significant cancer-related disparities among rural, Appalachian, Black and Hispanic populations.
Alliance program grantees will work to improve the coordination of patient care from diagnosis through survivorship; strengthen patient engagement in treatment decisions and overall patient-provider communication; build community partnerships that address barriers to care related to social determinants of health; and provide essential psychosocial support services.
Through the Alliance, the UK Markey Cancer Center will enhance coordination of care using digital tools to facilitate psychosocial screening, patient navigation, remote patient monitoring, and patient and provider education in collaboration with patient advocates and community partners.
“These efforts will address some of the social determinants of health that result in significant disparities in cancer outcomes in Kentucky,” said the project’s principal investigator Timothy Mullett, M.D., a professor of cardiothoracic surgery and the medical director of the UK Markey Cancer Center Affiliate and Research Networks.
“One of the biggest challenges faced by patients in rural communities is distance to quality cancer care,” Mullett said. “Technology connecting rural patients to the resources and expertise they need is just one strategy that can increase equity and access to cancer care in Kentucky and beyond.”
The Markey project is co-directed by Ming-Yuan Chih, Ph.D., associate professor in the College of Health Sciences, and Pamela Hull, Ph.D., an associate professor in the College of Medicine and Markey Cancer Center’s associate director of Population Science and Community Impact.
“The severity of the need to take action on advancing equity in cancer care cannot be overstated and will not be overlooked,” said Carmen Villar, CEO of the Merck Foundation. “We must move with urgency and work together to provide all people living with cancer access to high-quality care and treatment. The creation of the Alliance is an important step toward ensuring social determinants of health no longer factor into an individual’s ability to receive vital health care.”
In addition to the UK Markey Cancer Center, Alliance program grantees include Boston Medical Center; Case Comprehensive Cancer Center, Case Western Reserve University; Conquer Cancer®, the ASCO Foundation; Mary Bird Perkins Cancer Center; Memorial Sloan Kettering Cancer Center; and RWJBarnabas Health.
The Merck Foundation is also supporting a national program office at Virginia Commonwealth University (VCU) Massey Cancer Center, in partnership with the VCU Center on Health Disparities, which will assist Alliance program grantees in building partnerships with community-based organizations and provide technical assistance to support their programs. The National Program Office will also evaluate the effectiveness of Alliance programs and identify and promote best practices that can enhance the delivery of cancer care in the U.S.
Alliance program grantees will convene regularly with the National Program Office to discuss learnings, share insights and explore tangible actions to support the delivery of equitable cancer care within their local communities and beyond.
About the Merck Foundation
The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a leading global biopharmaceutical company, the Foundation is funded entirely by the company and is Merck’s chief source of funding support to qualified nonprofit charitable organizations. Since its inception, the Merck Foundation has contributed nearly $1 billion to support important initiatives that address critical global health and societal needs that are consistent with Merck’s purpose: to save and improve lives around the world. For more information, visit www.merck.com/company-overview/esg/philanthropy/.
As the state’s flagship, land-grant institution, the University of Kentucky exists to advance the Commonwealth. We do that by preparing the next generation of leaders — placing students at the heart of everything we do — and transforming the lives of Kentuckians through education, research and creative work, service and health care. We pride ourselves on being a catalyst for breakthroughs and a force for healing, a place where ingenuity unfolds. It's all made possible by our people — visionaries, disruptors and pioneers — who make up 200 academic programs, a $476.5 million research and development enterprise and a world-class medical center, all on one campus.
In 2022, UK was ranked by Forbes as one of the “Best Employers for New Grads” and named a “Diversity Champion” by INSIGHT into Diversity, a testament to our commitment to advance Kentucky and create a community of belonging for everyone. While our mission looks different in many ways than it did in 1865, the vision of service to our Commonwealth and the world remains the same. We are the University for Kentucky.